These data suggest that the p38 MAPK inhibitor inhibits MMP activity in ischemic stroke mainly through the modulation of MMP-9, which in this work has uncovered a novel MMP-associated regulatory pathway of ischemic stroke and brings new opportunities for stroke therapy. The gene discussed is MMP9; the disease is stroke disorder.